ID: ALA5220161

Max Phase: Preclinical

Molecular Formula: C14H12N2O4S

Molecular Weight: 304.33

Associated Items:

Representations

Canonical SMILES:  Cc1sc(NC(=O)c2cc(O)c(O)c(O)c2)c(C#N)c1C

Standard InChI:  InChI=1S/C14H12N2O4S/c1-6-7(2)21-14(9(6)5-15)16-13(20)8-3-10(17)12(19)11(18)4-8/h3-4,17-19H,1-2H3,(H,16,20)

Standard InChI Key:  FJMLBPCNWATYTO-UHFFFAOYSA-N

Associated Targets(non-human)

Staphylococcus coagulans 4 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Heyndrickxia coagulans 15 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Enterococcus faecalis 29875 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Klebsiella pneumoniae 43867 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Proteus vulgaris 5823 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 304.33Molecular Weight (Monoisotopic): 304.0518AlogP: 2.61#Rotatable Bonds: 2
Polar Surface Area: 113.58Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.62CX Basic pKa: CX LogP: 3.12CX LogD: 2.91
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.64Np Likeness Score: -1.27

References

1. Duvauchelle V, Meffre P, Benfodda Z..  (2022)  Recent contribution of medicinally active 2-aminothiophenes: A privileged scaffold for drug discovery.,  238  [PMID:35696863] [10.1016/j.ejmech.2022.114502]

Source